Bristol-Myers Squibb Company ($BMY) Insider Trading & Smart Money Activity

Bristol-Myers Squibb Company · Drug Manufacturers - General · Latest filing Oct 16, 2026

Bristol-Myers Squibb Company ($BMY) has 2 insider trades, 2 congress trades, 82 13F position changes and 2 analyst ratings on file. Insiders filed 2 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
0
Net insider $ (12 mo)
$0
Congress trades (12 mo)
1
13F moves on file
82
Analyst ratings on file
2

BMY insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 1 / 0 0 / 1
Q2 2026 0 0 0 / 0 45 / 30
Q3 2026 0 0 0 / 0 0 / 0
Q4 2026 0 0 0 / 0 4 / 2

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All BMY insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
13F Howard Capital Management Added +77.68K sh $7.73M —
13F Cantor Fitzgerald Investment Advisors L.P. Added +6.06K sh $16.54M —
13F Fort Washington Investment Advisors Reduced -588.08K sh $107.12M Read
13F Viking Fund Management Reduced -70K sh $23.28M —
13F Moody Lynn Lieberson & Walker New +58.24K sh $3.63M Read
13F Euro Pacific Asset Management New +3K sh $202.68K Read
Analyst Morgan Stanley Reiterates to Underweight PT $41 -0.7% —
Analyst Leerink Partners Lowers to Market Perform PT $59 -2.1% —
Insider Julia Haller Sell (Option exercise) 20.46K sh -2.7%+5.6% —
Insider Julia Haller Buy (Option exercise) 20.46K sh $1.10M -2.7%+5.6% —
13F California State Teachers Retirement System Reduced -77.66K sh $191.14M +1.2%-3.5% Read
13F Woodline Partners Added +51.52K sh $65.62M +4.3%-1.3% Read
13F Victory Capital Management Added +946.79K sh $527.29M +4.3%-1.3% —
13F Van Eck Associates Reduced -296.51K sh $591.02M +4.3%-1.3% —
13F Two Sigma Advisers Sold out -8.27M sh +4.3%-1.3% —
13F Trexquant Investment Reduced -378.43K sh $24.68M +4.3%-1.3% Read
13F Toronto Dominion Bank Reduced -430.74K sh $52.42M +4.3%-1.3% —
13F Tidal Investments Added +567.72K sh $40.84M +4.3%-1.3% —
13F State of Wisconsin Investment Board Added +28.10K sh $63.13M +4.3%-1.3% —
13F Quantinno Capital Management Added +170.32K sh $50.42M +4.3%-1.3% —
13F Price T Rowe Associates Added +3.37M sh $600.25M +4.3%-1.3% —
13F National Bank of Canada Reduced -723.37K sh $136M +4.3%-1.3% —
13F Mercer Global Advisors Added +127.57K sh $33.91M +4.3%-1.3% —
13F Manufacturers Life Insurance Company, the Added +241.41K sh $101.78M +4.3%-1.3% —
13F Man Group Reduced -2.66M sh $326.04M +4.3%-1.3% —
13F Gotham Asset Management Added +79.34K sh $49.68M +4.3%-1.3% —
13F FIL Reduced -213.36K sh $361.79M +4.3%-1.3% —
13F Cresset Asset Management Added +58.27K sh $23.77M +4.3%-1.3% —
13F Charles Schwab Investment Management Reduced -10.21M sh $3.58B +4.3%-1.3% —
Congress Alan Armstrong Purchase $1,001 - $15,000 +2.4%-0.3%+9.7% —
Congress Tommy Tuberville Sale $1,001 - $15,000 —

Showing 31 of 88 filings (the latest 13F moves are capped at 25; see the institutions below).

1W / 1M / 6M = how BMY moved from the trade or filing date.

Insider trading in BMY: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Julia Haller 2 — Jun 15, 2026

Members of Congress trading BMY

Institutions moving BMY (13F)

Analyst ratings on BMY

DateFirmActionRatingPrice target1W1M6MStory
Morgan Stanley Reiterates Underweight $40 → $41 -0.7% —
Leerink Partners Lowers Market Perform $73 → $59 -2.1% —

Frequently asked questions

What is the latest insider trade in BMY?

Julia Haller filed a sell (option exercise) of 20.46K sh on Jun 15, 2026.

Which members of Congress traded BMY?

2 disclosed trades by Alan Armstrong and Tommy Tuberville. The latest was on Mar 27, 2026.

Which institutions changed their BMY positions?

Recent 13F filers moving the stock include Fort Washington Investment Advisors, Howard Capital Management, Cantor Fitzgerald Investment Advisors L.P., Viking Fund Management and Moody Lynn Lieberson & Walker.

Other drug manufacturers - general stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text